Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deubiquitinating protein VCPIP1 (VCPIP1) is an **OTU-domain deubiquitinating enzyme** involved in diverse cellular processes, including **protein deubiquitination, DNA-protein cross-link repair, reassembly of the Golgi apparatus and endoplasmic reticulum after mitosis, and protein localization to chromatin**[5]. VCPIP1 interacts with the **valosin-containing protein (VCP/p97), P47, and the SNARE complex** to promote **membrane fusion events** essential for Golgi and ER integrity post-mitosis[1][3]. It can recruit proteasome subunits, such as **PSMC3**, and regulate stability of specific proteins like the **hepatitis B virus X protein (HBx)**, linking it to viral infection and oncogenesis[2][4]. **VCPIP1’s activity spans both enzymatic and scaffolding functions** independent of its DUB activity[2]. Genetic alterations in VCPIP1 or its interacting partners are associated with **cancer, neurodegenerative diseases, and rare genetic syndromes**[5]. While inhibitors targeting VCPIP1 are under investigation, none are currently clinically approved, and the essential nature of its cellular roles suggests a need for caution to avoid disrupting fundamental protein homeostasis[5].
Drugs targeting deubiquitinating enzymes often act by inhibiting or modulating enzymatic deubiquitination activity, but specific mechanism for direct VCPIP1 modulators not established as of current knowledge[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deubiquitinating protein VCPIP1 (VCPIP1).